Drug repurposing unveils new combinatorial treatments to treat mutant KRAS lung cancer

ABSTRACT: We report data on a drug combination with synergistic antitumor effect in KRAS-driven lung cancer. We used RNAseq to characterize the transcriptional changes elicited by each drug in a mutant KRAS lung cancer cell lines (H1792)

ORGANISM(S): Homo sapiens

PROVIDER: GSE161218 | GEO | 2023/08/10

REPOSITORIES: GEO